Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lamparelli

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Transplantation|August 15, 1996
Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantationA Bacigalupo, S Bregante, E Tedone, et al.
Blood|April 1, 1991
Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemiaA Bacigalupo, M T Van Lint, D Occhini, et al.
Bone Marrow Transplantation|November 1, 1996
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct)A Bacigalupo, S Bregante, E Tedone, et al.
Haematologica|January 12, 2000
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaA M Raiola, M T Van Lint, T Lamparelli, et al.
British Journal of Haematology|February 13, 2001
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell doseA Dominietto, A M Raiola, M T van Lint, et al.
Bone Marrow Transplantation|August 26, 1998
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised studyS Moretti, P Zikos, M T Van Lint, et al.
Haematologica|November 27, 1998
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapseP Zikos, M T Van Lint, T Lamparelli, et al.
British Journal of Haematology|January 29, 2000
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationA Bacigalupo, V Vitale, R Corvò, et al.
Bone Marrow Transplantation|April 5, 2011
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCTA Dominietto, E Tedone, M Soracco, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2010
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsM Mikulska, V Del Bono, R Prinapori, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Transplantation|August 15, 1996
Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantationA Bacigalupo, S Bregante, E Tedone, et al.
Blood|April 1, 1991
Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemiaA Bacigalupo, M T Van Lint, D Occhini, et al.
Bone Marrow Transplantation|November 1, 1996
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct)A Bacigalupo, S Bregante, E Tedone, et al.
Haematologica|January 12, 2000
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuriaA M Raiola, M T Van Lint, T Lamparelli, et al.
British Journal of Haematology|February 13, 2001
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell doseA Dominietto, A M Raiola, M T van Lint, et al.
Bone Marrow Transplantation|August 26, 1998
Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised studyS Moretti, P Zikos, M T Van Lint, et al.
Haematologica|November 27, 1998
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapseP Zikos, M T Van Lint, T Lamparelli, et al.
British Journal of Haematology|January 29, 2000
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationA Bacigalupo, V Vitale, R Corvò, et al.
Bone Marrow Transplantation|April 5, 2011
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCTA Dominietto, E Tedone, M Soracco, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2010
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsM Mikulska, V Del Bono, R Prinapori, et al.
Pageof 7